Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Treatment of ureteral anastomotic strictures with reimplantation and survival after cystectomy and urinary diversion.

Helfand AM, Beach R, Hadj-Moussa M, Krishnan N, He C, Montgomery JS, Morgan TM, Weizer AZ, Hafez K, Lee CT, Stoffel JT, Skolarus TA.

Urol Oncol. 2016 Aug 29. pii: S1078-1439(16)30204-6. doi: 10.1016/j.urolonc.2016.07.018. [Epub ahead of print]

PMID:
27595462
2.

Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.

Scherr KA, Fagerlin A, Hofer T, Scherer LD, Holmes-Rovner M, Williamson LD, Kahn VC, Montgomery JS, Greene KL, Zhang B, Ubel PA.

Med Decis Making. 2016 Aug 10. pii: 0272989X16662841. [Epub ahead of print]

PMID:
27510740
3.

Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?

Ambani SN, Morgan TM, Montgomery JS, Gadzinski AJ, Jacobs BL, Hawken S, Krishnan N, Caoili EM, Ellis JH, Kunju LP, Hafez KS, Miller DC, Palapattu GS, Weizer AZ, Wolf JS Jr.

Urology. 2016 Jul 19. pii: S0090-4295(16)30424-1. doi: 10.1016/j.urology.2016.04.067. [Epub ahead of print]

PMID:
27450936
4.

A Multi-Center International Study Assessing the Impact of Differences in Baseline Characteristics and Perioperative Care Following Radical Cystectomy.

Osawa T, Lee CT, Abe T, Takada N, Hafez KS, Montgomery JS, Weizer AZ, Hollenbeck BK, Skolarus TA, Murai S, Shinohara N, Morgan TM.

Bladder Cancer. 2016 Apr 27;2(2):251-261.

5.

Using Analytic Morphomics to Understand Short-Term Convalescence after Radical Cystectomy.

Luckenbaugh AN, Hollenbeck BK, Montgomery JS, Lee CT, Gilbert SM, Dunn RL, Friedman JF, Englesbe MJ, Wang SC, Hollingsworth JM.

Bladder Cancer. 2016 Apr 27;2(2):235-240.

6.

Patient-Reported Convalescence and Quality of Life Recovery: A Comparison of Open and Robotic-Assisted Radical Cystectomy.

Li AY, Filson CP, Hollingsworth JM, He C, Weizer AZ, Hollenbeck BK, Gilbert SM, Hafez KS, Lee CT, Dunn RL, Montgomery JS.

Surg Innov. 2016 Jun 28. pii: 1553350616656284. [Epub ahead of print]

PMID:
27354552
7.

Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal Tumors.

Osawa T, Hafez KS, Miller DC, Montgomery JS, Morgan TM, Palapattu GS, Weizer AZ, Caoili EM, Ellis JH, Kunju LP, Wolf JS Jr.

Urology. 2016 Jun 1. pii: S0090-4295(16)30255-2. doi: 10.1016/j.urology.2016.05.044. [Epub ahead of print]

PMID:
27262393
8.

Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.

Pearce SM, Golan S, Gorin MA, Luckenbaugh AN, Williams SB, Ward JF, Montgomery JS, Hafez KS, Weizer AZ, Pierorazio PM, Allaf ME, Eggener SE.

Eur Urol. 2016 May 24. pii: S0302-2838(16)30181-6. doi: 10.1016/j.eururo.2016.05.017. [Epub ahead of print]

PMID:
27234998
9.

Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.

Udager AM, Liu TY, Skala SL, Magers MJ, McDaniel AS, Spratt DE, Feng FY, Siddiqui J, Cao X, Fields KL, Morgan TM, Palapattu GS, Weizer AZ, Chinnaiyan AM, Alva A, Montgomery JS, Tomlins SA, Jiang H, Mehra R.

Ann Oncol. 2016 Sep;27(9):1706-12. doi: 10.1093/annonc/mdw216. Epub 2016 May 23.

PMID:
27217541
10.

Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy.

Kozminski MA, Tomlins S, Cole A, Singhal U, Lu L, Skolarus TA, Palapattu GS, Montgomery JS, Weizer AZ, Mehra R, Hollenbeck BK, Miller DC, He C, Feng FY, Morgan TM.

Urol Oncol. 2016 Sep;34(9):415.e1-6. doi: 10.1016/j.urolonc.2016.03.019. Epub 2016 Apr 29.

PMID:
27140065
11.

A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor.

Anderson C, Weber R, Patel D, Lowrance W, Mellis A, Cookson M, Lang M, Barocas D, Chang S, Newberger E, Montgomery JS, Weizer AZ, Lee CT, Kava BR, Jackson M, Meraney A, Sjoberg D, Bochner B, Dalbagni G, Donat M, Herr H.

J Urol. 2016 Oct;196(4):1014-20. doi: 10.1016/j.juro.2016.03.151. Epub 2016 Apr 1.

PMID:
27044571
12.

Independent Surgical Validation of the New Prostate Cancer Grade Grouping System.

Spratt DE, Cole AI, Palapattu GS, Weizer AZ, Jackson WC, Montgomery JS, Dess R, Zhao SG, Lee JY, Wu A, Kunju LP, Talmich E, Miller DC, Hollenbeck BK, Tomlins SA, Feng FY, Mehra R, Morgan TM.

BJU Int. 2016 Mar 24. doi: 10.1111/bju.13488. [Epub ahead of print]

PMID:
27009882
13.

Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.

Cole AI, Morgan TM, Spratt DE, Palapattu GS, He C, Tomlins SA, Weizer AZ, Feng FY, Wu A, Siddiqui J, Chinnaiyan AM, Montgomery JS, Kunju LP, Miller DC, Hollenbeck BK, Wei JT, Mehra R.

J Urol. 2016 Aug;196(2):405-11. doi: 10.1016/j.juro.2016.01.120. Epub 2016 Feb 23.

PMID:
26920466
14.

Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.

McDaniel AS, Hovelson DH, Cani AK, Liu CJ, Zhai Y, Zhang Y, Weizer AZ, Mehra R, Feng FY, Alva AS, Morgan TM, Montgomery JS, Siddiqui J, Sadis S, Bandla S, Williams PD, Cho KR, Rhodes DR, Tomlins SA.

Cancer Res. 2015 Dec 15;75(24):5219-27. doi: 10.1158/0008-5472.CAN-15-1004.

PMID:
26670561
15.

Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.

Osawa T, Hafez KS, Miller DC, Montgomery JS, Morgan TM, Palapattu GS, Weizer AZ, Caoili EM, Ellis JH, Kunju LP, Wolf JS Jr.

J Urol. 2016 Mar;195(3):574-80. doi: 10.1016/j.juro.2015.10.137. Epub 2015 Oct 30.

PMID:
26523883
16.

Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.

Magers MJ, Zhan T, Udager AM, Wei JT, Tomlins SA, Wu AJ, Kunju LP, Lew M, Feng FY, Hamstra DA, Siddiqui J, Chinnaiyan AM, Montgomery JS, Weizer AZ, Morgan TM, Hollenbeck BK, Miller DC, Palapattu GS, Jiang H, Mehra R.

Med Oncol. 2015 Nov;32(11):249. doi: 10.1007/s12032-015-0693-9. Epub 2015 Oct 6.

PMID:
26442515
17.

Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy.

Ahmadi H, Montie JE, Weizer AZ, Morgan T, Montgomery JS, Lee CT.

Curr Urol Rep. 2015 Nov;16(11):79. doi: 10.1007/s11934-015-0548-0. Review.

PMID:
26403157
18.

Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.

Holmes-Rovner M, Montgomery JS, Rovner DR, Scherer LD, Whitfield J, Kahn VC, Merkle EC, Ubel PA, Fagerlin A.

Med Decis Making. 2015 Nov;35(8):999-1009. doi: 10.1177/0272989X15597226. Epub 2015 Aug 24.

PMID:
26304063
19.

Inguinal and Scrotal Lesion. Extramammary Paget disease.

Ballard TN, Montgomery JS, Kozlow JH.

JAMA Oncol. 2015 Apr;1(1):107-8. doi: 10.1001/jamaoncol.2014.260. No abstract available.

PMID:
26182312
20.

A Generalized Assessment of the Impact of Regionalization and Provider Learning on Patient Outcomes.

Zhang Y, Lee SD, Gilleskie DB, Sun Y, Padakandla A, Jacobs BL, Montgomery JS, Montie JE, Wei JT, Hollenbeck BK.

Med Decis Making. 2015 Jul 13. pii: 0272989X15593282. [Epub ahead of print]

PMID:
26169752
Items per page

Supplemental Content

Loading ...
Write to the Help Desk